FR5132M - - Google Patents
Info
- Publication number
- FR5132M FR5132M FR46556A FR46556A FR5132M FR 5132 M FR5132 M FR 5132M FR 46556 A FR46556 A FR 46556A FR 46556 A FR46556 A FR 46556A FR 5132 M FR5132 M FR 5132M
- Authority
- FR
- France
- Prior art keywords
- tablets
- lysozyme
- amylase
- jan
- suitably
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 102000016943 Muramidase Human genes 0.000 abstract 3
- 108010014251 Muramidase Proteins 0.000 abstract 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 3
- 229940088598 enzyme Drugs 0.000 abstract 3
- 235000010335 lysozyme Nutrition 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000004382 Amylase Substances 0.000 abstract 2
- 102000013142 Amylases Human genes 0.000 abstract 2
- 108010065511 Amylases Proteins 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 235000019418 amylase Nutrition 0.000 abstract 2
- 229960000274 lysozyme Drugs 0.000 abstract 2
- 239000004325 lysozyme Substances 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- 102000002322 Egg Proteins Human genes 0.000 abstract 1
- 108010000912 Egg Proteins Proteins 0.000 abstract 1
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 1
- 239000001166 ammonium sulphate Substances 0.000 abstract 1
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000000440 bentonite Substances 0.000 abstract 1
- 229910000278 bentonite Inorganic materials 0.000 abstract 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000014103 egg white Nutrition 0.000 abstract 1
- 210000000969 egg white Anatomy 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 210000004251 human milk Anatomy 0.000 abstract 1
- 235000020256 human milk Nutrition 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 108010032809 mucopolysaccharidase Proteins 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 229940051921 muramidase Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000006190 sub-lingual tablet Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 210000001138 tear Anatomy 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- -1 unit dosage packets Substances 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR46556A FR5132M (enrdf_load_stackoverflow) | 1966-01-20 | 1966-01-20 | |
GB178567A GB1171183A (en) | 1966-01-20 | 1967-01-12 | Pharmaceutical Compositions containing Enzymes |
BE692682D BE692682A (enrdf_load_stackoverflow) | 1966-01-20 | 1967-01-16 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR46556A FR5132M (enrdf_load_stackoverflow) | 1966-01-20 | 1966-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR5132M true FR5132M (enrdf_load_stackoverflow) | 1967-06-05 |
Family
ID=8599230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR46556A Expired FR5132M (enrdf_load_stackoverflow) | 1966-01-20 | 1966-01-20 |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE692682A (enrdf_load_stackoverflow) |
FR (1) | FR5132M (enrdf_load_stackoverflow) |
GB (1) | GB1171183A (enrdf_load_stackoverflow) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9207280D0 (en) * | 1992-04-02 | 1992-05-13 | Unilever Plc | Skin care method and composition |
GB9207288D0 (en) * | 1992-04-02 | 1992-05-13 | Unilever Plc | Cosmetic composition |
-
1966
- 1966-01-20 FR FR46556A patent/FR5132M/fr not_active Expired
-
1967
- 1967-01-12 GB GB178567A patent/GB1171183A/en not_active Expired
- 1967-01-16 BE BE692682D patent/BE692682A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BE692682A (enrdf_load_stackoverflow) | 1967-07-03 |
GB1171183A (en) | 1969-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Anhalt et al. | Special Tests: Bactericidal Activity, Activity of Antimicrobics in Combination, and Detection of beta-Lactamase Production. | |
IE812972L (en) | Actaplanin derivatives | |
MY104013A (en) | Drug adsorbates. | |
WO2000050069A1 (en) | A means for the prophylactic and therapeutic treatment of streptococcal infections | |
DE3877226D1 (de) | Inhibitoren des angiotensin-umwandlungsenzyms enthaltende stabilisierte arzneimittel. | |
GB1510925A (en) | Chromogenic enzyme substrates | |
ATE261494T1 (de) | Konstrukte zur verabreichung von therapeutischen wirkstoffen an die neuronzellen | |
US3590121A (en) | Effervescent dental compositions | |
Woollen et al. | Studies on glucosaminidase. 6. N-Acetyl-β-glucosaminidase and N-acetyl-β-galactosaminidase activities of a variety of enzyme preparations | |
FR5132M (enrdf_load_stackoverflow) | ||
GB1306264A (enrdf_load_stackoverflow) | ||
IE36619L (en) | Enzymes for reducing dental plaque | |
DK197089D0 (da) | Laegemidler indeholdende pentamidin | |
ATE218368T1 (de) | Medikament welches protein c aktivierendes peptid enthält | |
GB1196971A (en) | Production of Fortified Sugar | |
GB1224281A (en) | Process for purifying starch and purified starch and products containing same | |
Kaji et al. | Purification and properties of acid β-D-galactosidase from Corticium rolfsii | |
IE810808L (en) | Isophthalic acid picolylamide monohydrate | |
IE34609L (en) | Therapeutic substituted thiazolidinedione | |
GB1235540A (en) | Oral preparations containing proteolytic enzymes suitable for pediatric use | |
GB1313318A (en) | Pharmaceutical preparation for the treatment of hemorrhoids | |
CA2046598A1 (en) | T-pa solubilisation | |
IT1214915B (it) | Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione | |
Rau et al. | Influence of pH on the diastatic activity of fungal and malt amylases | |
IE35226B1 (en) | Pharmaceutical preparations |